X4 Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Go back to X4 Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
(NASDAQ: XFOR) Delayed: 4.00 -0.12 (2.91%)
Previous Close $4.12    52 Week High
Open $4.06    52 Week Low
Day High $4.22    P/E N/A 
Day Low $3.99    EPS
Volume 352,725